| Literature DB >> 20941364 |
Patrick Schütz1, Tobias Karlberg, Susanne van den Berg, Ruairi Collins, Lari Lehtiö, Martin Högbom, Lovisa Holmberg-Schiavone, Wolfram Tempel, Hee-Won Park, Martin Hammarström, Martin Moche, Ann-Gerd Thorsell, Herwig Schüler.
Abstract
DEAD-box RNA helicases play various, often critical, roles in all processes where RNAs are involved. Members of this family of proteins are linked to human disease, including cancer and viral infections. DEAD-box proteins contain two conserved domains that both contribute to RNA and ATP binding. Despite recent advances the molecular details of how these enzymes convert chemical energy into RNA remodeling is unknown. We present crystal structures of the isolated DEAD-domains of human DDX2A/eIF4A1, DDX2B/eIF4A2, DDX5, DDX10/DBP4, DDX18/myc-regulated DEAD-box protein, DDX20, DDX47, DDX52/ROK1, and DDX53/CAGE, and of the helicase domains of DDX25 and DDX41. Together with prior knowledge this enables a family-wide comparative structural analysis. We propose a general mechanism for opening of the RNA binding site. This analysis also provides insights into the diversity of DExD/H- proteins, with implications for understanding the functions of individual family members.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20941364 PMCID: PMC2948006 DOI: 10.1371/journal.pone.0012791
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of previously established roles and functions for the RNA helicases covered in this study.
| Helicase | Function |
|
| DDX2A (eIF4A1) is essential for translation initiation. It is part of the eIF4F complex that consists of eIF4G, eIF4E and eIF4A |
|
| Also known as eIF4A2, an isoform of DDX2A. |
|
| DDX5 is a co-regulator of different transcription factors including ERα, p53, MyoD and Runx2, but ATPase/helicase activity is not required for transcriptional co-regulation. DDX5 also participates in pre-RNA processing, alternative splicing, microRNA and ribosomal RNA processing (reviewed in ref. |
|
| DDX10 is probably involved in ribosome assembly. Fusion of the nucleoporin gene NUP98 with the DDX10 gene leads to the NUP98-DDX10 gene product. This fusion protein is involved in leukemogenesis |
|
| DDX18 (Myc-regulated DEAD-box protein, or MrDP; |
|
| DDX20 (Gemin3) is a component of the SMN (Survival of Motor Neurons) complex that is involved in assembly and reconstruction of different RNP (ribonucleoprotein) complexes |
|
| DDX25 (GRTH) is a testis specific, gonadotropin and androgen regulated protein that is essential for completion of spermatogenesis |
|
| DDX41 (Abstrakt) post-transcriptionally regulates the expression levels of the insc protein that is essential for control of cell polarity and spindle orientation |
|
| DDX47 is involved in pre-rRNA processing. It interacts with NOP132 which recruits pre-rRNA processing proteins to the region within the nucleolus were rRNA is transcribed |
|
| DDX52 (Rok1) is required for the release of snR30 (small nucleolar RNA-30) from pre-ribosomes. snR30 is one of three snoRNAs that are critical for pre-rRNA processing in yeast. DDX52 ATPase activity is important for optimal pre-ribosomal RNA processing, but not essential for release of snR30 |
|
| DDX53 (CAGE) is expressed in testis and various tumors, but not in other tissues. Expression of the CAGE-gene is determined by its methylation status |
Summary of crystallographic data analysis and refinement statistics*.
|
| DDX2A | DDX2B | DDX5 | DDX10 | DDX18 | DDX20 | DDX25 | DDX41 | DDX47 | DDX52 | DDX53 |
|
| DEAD | DEAD | DEAD | DEAD | DEAD | DEAD | helicase | helicase | DEAD | DEAD | DEAD |
|
| 2G9N | 3BOR | 3FE2 | 2PL3 | 3LY5 | 3B7G | 2RB4 | 2P6N | 3BER | 3DKP | 3IUY |
|
| - | - | ADP | ADP | PO4 | AMPPNP | - | - | AMP | ADP | AMP |
|
| ESRF ID14-2 | APS 19-ID | BESSY 14.2 | MAX II I911-2 | DIAMOND I04 | ESRF ID29 | BESSY 14.2 | ESRF ID14-4 | ESRF ID29 | ESRF ID23-1 | ESRF ID14-2 |
|
| 0.93300 | 0.97242 | 0.9184 | 1.04123 | 0.9789 | 1.00595 | 0.95373 | 1.04005 | 0.97472 | 1.00000 | 0.97930 |
|
| P 1 21 1 | P 21 21 2 | C 2 2 21 | P 61 2 2 | P 31 | P 31 2 1 | P 43 21 2 | P 65 2 2 | C 1 2 1 | P 1 21 1 | P 1 21 1 |
|
| |||||||||||
| a, b, c (Å) | a = 47.8,b = 78.25, c = 59.09 | a = 58.09, b = 80.1, c = 42.74 | a = 84.57, b = 106.87, c = 117.32 | a = 63.5, b = 63.5, c = 304.01 | a = 41.34, b = 41.34, c = 230.54 | a = 63.56, b = 63.56, c = 214.6 | a = 70.31, b = 70.31, c = 187.12 | a = 68.01, b = 68.01, c = 305.6 | a = 93.05, b = 70.37, c = 35.86 | a = 40.63, b = 38.36, c = 73.84 | a = 56.44, b = 61.25, c = 65.79 |
| α, β, γ (°) | α = 90, β = 103.43, γ = 90 | α = 90, β = 90, γ = 90 | α = 90, β = 90, γ = 90 | α = 90, β = 90, γ = 120 | α = 90, β = 90, γ = 120 | α = 90, β = 90, γ = 120 | α = 90, β = 90, γ = 90 | α = 90, β = 90, γ = 120 | α = 90, β = 90.7, γ = 90 | α = 90, β = 90.37, γ = 90 | α = 90, β = 96.36, γ = 90 |
|
| 2.37–2.25 | 1.92–1.85 | 2.67–2.60 | 2.30–2.15 | 2.85–2.7 | 2.00–1.90 | 2.90–2.80 | 2.80–2.60 | 1.50–1.40 | 2.20–2.10 | 2.53–2.40 |
|
| 0.07 (0.24) | 0.14 (0.67) | 0.14 (0.74) | 0.05 (0.16) | 0.24 (1.29) | 0.081 (0.13) | 0.11 (0.82) | 0.10 (0.45) | 0.05 (0.14) | 0.09 (0.38) | 0.20 (0.61) |
|
| 7.4 (5.3) | 27.6 (3.8) | 11.0 (2.4) | 54.1 (24.5) | 6.2 (2.0) | 32.10 (21.3) | 15.65 (2.6) | 35.9 (12.6) | 28.7 (14.1) | 12.8 (4.6) | 13.4 (4.2) |
|
| 99.7 (100.0) | 100 (99.9) | 99.4 (99.8) | 99.7 (100.0) | 99.98 (100.0) | 99.7 (100.0) | 100.0 (100.0) | 99.9 (100.0) | 99.5 (100.0) | 99.5 (99.8) | 100.0 (100.0) |
|
| 7.4 (3.5) | 11.4 (10.1) | 4.0 (4.0) | 25.4 (26.5) | 5.1 (5.5) | 20.5 (18.2) | 8.8 (9.1) | 40.0 (41.8) | 7.3 (7.3) | 3.7 (3.7) | 9.3 (9.5) |
|
| |||||||||||
|
| 20–2.25 | 30–1.85 | 35–2.6 | 30–2.15 | 38.4–2.8 | 38.43–1.90 | 19.44–2.80 | 29.72–2.60 | 28.24–1.40 | 19.56–2.10 | 45.13–2.40 |
|
| 19100 | 17560 | 15770 | 19842 | 10358 | 38606 | 11208 | 13220 | 43193 | 12804 | 17613 |
|
| 0.1761/0.2573 | 0.185/0.226 | 0.205/0.273 | 0.210/0.248 | 0.246/0.274 | 0.172/0.202 | 0.233/0.267 | 0.243/0.294 | 0.165/0.189 | 0.182/0.236 | 0.201/0.251 |
|
| |||||||||||
| Protein | 15 | 21 | 27 | 48 | 47 | 18 | 82 | 57 | 13 | 23 | 23 |
| Water | 17 | 17 | 20 | 45 | 29 | 29 | 53 | 28 | 17 | 25 | |
| Ligand | 27 | 43 | 36 | 26 | 14 | 12 | 17 | ||||
|
| |||||||||||
| Bond lengths (Å) | 0.018 | 0.015 | 0.012 | 0.017 | 0.007 | 0.014 | 0.01 | 0.016 | 0.014 | 0.013 | 0.007 |
| Bond angles (°) | 1.732 | 1.344 | 1.354 | 1.695 | 0.952 | 1.648 | 1.244 | 1.602 | 1.638 | 1.414 | 1.157 |
|
| |||||||||||
| Favored regions (%) | 96.0 | 99.5 | 98.3 | 98.2 | 96.88 | 98.8 | 91.4 | 95.2 | 99.6 | 99.6 | 98.8 |
| Allowed regions (%) | 99.2 | 100 | 100 | 100 | 100 | 100 | 99.7 | 100 | 100 | 100 | 100 |
*Values in parentheses refer to the outermost resolution shell.
Rmeas as described in [71].
Rsym as described in [72].
Calculated using Rmerge, Version 2 [73].
Calculated as the ratio of average I over average error.
Determined using Molprobity [74].
Figure 1Crystal structures of DEAD-box conserved domains-1 and -2.
(A) Superposition of the DEAD-domains of DDX2A (green), DDX2B (brown), DDX5 (red), DDX10 (turquoise), DDX18 (grey), DDX47 (dark blue), DDX52 (yellow), and DDX53 (dark yellow). The positions of conserved motifs I–III (black) are indicated. (B) Superposition of the helicase domains of DDX19 (light blue), DDX25 (grey) and DDX41 (orange). The positions of conserved motifs IV–VI (black) are indicated. (C) Cartoon representations of the DDX5 helicase domain in the same orientations as in the following two panels. (D) Conserved surface patches (green), projected onto the DDX47 DEAD-domain surface. (E) Electrostatic surface representation of DEAD-domains. Negative charges are shown in red and positive charges in blue. (F) Cartoon representations of the DDX41 helicase domain in the same orientation as in the following two panels. The RNA and AMPPNP (sticks representation) of the superposed DDX19 structure mark the RNA and nucleotide binding sites. (G) Conserved surface patches (green), projected onto the DDX25 helicase-domain surface. (H) Electrostatic surface representation of helicase domains.
Figure 2Sequence alignments of the two RecA-like domains of the DEAD-box proteins described in this study.
Conserved sequence motifs are indicated. Secondary structural elements are given for DDX19 (PDB entry 3G0H) above the alignment. Asterisks mark the terminal aspartate of the DEAD motif and the arginine of motif V, the interaction of which is central to positioning of α-helix 8 (see also Figure 5C, D). Sequences shown are human DDX19B (gene accession number: 13177688); DDX10 (13514831); DDX18 (38327634); DDX20 (23270929); DDX25 (29792166); DDX41 (21071032); DDX47 (45786091); DDX5 (16359122); DDX52 (27697141); DDX53 (45709415); eIF4A1/DDX2A (16307020); and eIF4A2/DDX2B (45645183).
Figure 5Details of the RNA binding cleft.
(A) DDX19 closed state structure (PDB entry 3G0H). DDX19-bound RNA, Mg2+-ion and AMPPNP are in orange. (B) Superposition of several DEAD domain structures showing a conserved conformation of α-helix 8. (C) Interactions between the DEAD and helicase domains of DDX19. (D) “Top-down” view of the open and closed RNA binding cleft. DDX5 (red), the ATP-state of DDX19 (blue) and DDX41 (orange) are shown. RNA (superposed from the DDX19 complex structure) is shown in light orange. (E) Surface representation of the DDX19-RNA complex. Note that α-helix 8 does not come in contact with the RNA substrate. (F) Surface representation of DDX5 and the superposed RNA from the DDX19 complex structure. Note that α-helix 8 would clash with the RNA substrate.
Figure 3Details of the ATP binding sites.
(A) Superposition of multiple DEAD-domains to illustrate variability in P-loop (Motif I) conformations. P-loops in DEAD-domain structures with bound phosphate (yellow), with bound AMP (orange), with bound ADP (red), DDX19 P-loop with bound AMPPNP and Mg2+ (blue), DDX20 P-loop with bound AMPPNP (magenta), and P-loop in nucleotide-free eIF4A/DDX2A (green) are shown. Motifs I, II and III are indicated. (B) Two different conformations of the β- and γ-phosphates in the DDX20-AMPPNP complex. Side chains that interact with the AMPPNP are shown as balls-and-sticks. (C) DDX2B with a closed P-loop. The α-helix that follows the P-loop starts one turn earlier compared to other DEAD-domain structures shown. (D) Variability of interactions with the adenosine nucleotide. The adenosine moiety is coordinated through π-stacking interactions or hydrophobic interactions. Numbers denote the interaction surface, in Å2, between the nucleotide and the stacking side chain, as determined using the PISA server [25].
Figure 4RNA binding cleft on DEAD domains.
(A) DDX19 (light blue; PDB entry 3G0H) with bound RNA (light orange). RNA-interacting side chains are shown. (B) Flexible regions in DDX2B, DDX10 and DDX53 for which the electron density was not visible. (C) Sequence conservation in the RNA binding cleft, mapped onto the DDX47 structure (red, conserved; orange, partly conserved). (D) RNA binding sites of selected DEAD-domains to illustrate their sequence variation.
Figure 6Schematic model for the regulation of RNA binding by α-helix 8 of DEAD-box helicases.
(A) In the isolated domains, reflecting the open and substrate free states, the RNA binding sites are partially blocked by α-helix 8 in the DEAD-domain and motif V in the helicase domain. The aspartate indicated in the DEAD-domain is the second D of the DEAD sequence in motif II. The arginine indicated in the helicase domain is a conserved residue in motif V. Both residues are marked by asterisks in Fig 2. (B) Binding of ATP favors closure of the cleft, facilitating interaction of α-helix 8 with motif V across the cleft, thereby removing the blockage of the RNA binding site. (C) The closed cleft conformation is stabilized by RNA substrate to the competent site, allowing ATP hydrolysis to proceed.